Search Within

Craig Moskowitz

Formats
  1. Meeting Abstract (229)
  2. Journal Article (174)
  3. Book Section (3)
  4. Research Letter (1)
Groups
  1. Department of Medicine (407)
  2. Hematologic Malignancies, Division of (407)
  3. Center for Hematologic Malignancies (288)
  4. Lymphoma (273)
  5. Survivorship Research (176)
  6. Epidemiology and Biostatistics (103)

More Groups

People
  1. Andrew Zelenetz (207)
  2. David Straus (117)
  3. Paul Hamlin (113)
  4. Carol Portlock (106)
  5. Ariela Noy (94)
  6. Matthew Matasar (91)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (3)
  4. 2021 (4)
  5. 2020 (6)
  6. 2019 (8)

More Years

Publications
  1. Blood (160)
  2. Journal of Clinical Oncology (46)
  3. Biology of Blood and Marrow Transplantation (23)
  4. Annals of Oncology (17)
  5. British Journal of Haematology (17)
  6. Haematologica (16)

More Publications

Publishers
  1. American Society of Hematology (165)
  2. American Society of Clinical Oncology (46)
  3. Elsevier Inc. (44)
  4. Oxford University Press (20)
  5. John Wiley & Sons (18)
  6. Ferrata Storti Foundation (16)

More Publishers

Results (407)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT CTN 0401 trial
    Journal Article

    Vose, J. M.; Carter, S.; Burns, L. J.; Ayala, E.; Press, O. W.; Moskowitz, C. H.; Stadtmauer, E. A.; Mineshi, S.; Ambinder, R.; Fenske, T.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Tumor associated macrophages in relapsed and refractory Hodgkin lymphoma
    Journal Article

    Casulo, C.; Arcila, M.; Bohn, O. L.; Teruya-Feldstein, J.; Maragulia, J.; Moskowitz, C. H.
    Leukemia Research (2013)

    Fulltext@MSK | Save
  • High dose therapy and autologous stem cell transplantation results in good outcomes and acceptable toxicities in elderly patients with non-Hodgkin's lymphoma
    Meeting Abstract

    Tamari, R.; Dahi, P.; Devlin, S.; Goldberg, J.; Hamlin, P.; Matasar, M.; Maragulia, J.; Perales, M. A.; Moskowitz, C. H.; Sauter, C. S.
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • Remission duration ≤ 12 months for early relapsed and refractory follicular lymphoma is predictive of early failures post-high dose therapy and autologous stem cell rescue
    Meeting Abstract

    Lunning, M. A.; Maragulia, J.; Moskowitz, C. H.; Castro-Malaspina, H.; Giralt, S. A.; Zelenetz, A. D.; Sauter, C. S.
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Hamlin, P. A. Jr; Perales, M. A.; Gerecitano, J.; Horwitz, S. M.; Matasar, M. J.; Noy, A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Controversies in BMT for Lymphoma
    Journal Article

    Gascoyne, R. D.; Moskowitz, C.; Shea, T. C.
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • Pilot study of dacetuzumab in combination with rituximab and gemcitabine for relapsed or refractory diffuse large B-cell lymphoma
    Journal Article

    Forero-Torres, A.; Bartlett, N.; Beaven, A.; Myint, H.; Nasta, S.; Northfelt, D. W.; Whiting, N. C.; Drachman, J. G.; Lobuglio, A. F.; Moskowitz, C. H.
    Leukemia and Lymphoma (2013)

    Fulltext@MSK | Save
  • High-dose chemotherapy (HDC) followed by autologous stem cell transplant (ASCT) for recurrent/progressive CNS lymphoma
    Meeting Abstract

    Welch, M. R.; Sauter, C. S.; Matasar, M. J.; Moskowitz, C.; Omuro, A. M. P.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Rituximab, methotrexate (MTX), procarbazine, and vincristine (R-MPV) followed by consolidation high-dose chemotherapy (HDC) and autologous stem-cell transplant (ASCT) for newly diagnosed primary CNS lymphoma (PCNSL)
    Meeting Abstract

    Omuro, A. M. P.; Correa, D.; Moskowitz, C.; Matasar, M. J.; DeAngelis, L. M.; Kaley, T. J.; Gavrilovic, I. T.; Nolan, C.; Pentsova, E.; Grommes, C.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Interim PET-CT in the management of diffuse large B-cell lymphoma
    Journal Article

    Moskowitz, C. H.
    Hematology-American Society of Hematology Education Program (2012)

    Fulltext@MSK | Save